BH2996H

N/A

Report date: 2025/02/18 17:22:54

Base Information

Drug NameBH2996H

Drug Alias NameBH-2996hBH2996H

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionImmunomodulatorsAnti-Programmed death-ligand 1Anti-PD-1

TargetsProgrammed death-ligand 1Programmed cell death protein 1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesHanmi Pharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesHanmi Pharmaceutical Co Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A